Clinical trial
GALectin-3 Binding Protein for Risk Assessment in Coronary arTery dIsease and Chronic Heart Failure
NCT01210157 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GALectin-3 Binding Protein for Risk Assessment in Coronary arTery dIsease and Chronic Heart Failure
- Lead sponsor
- Heidelberg University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- August 31, 2010
- Enrollment
- 373 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.